110 related articles for article (PubMed ID: 23794243)
1. Characterization of the stereochemical structures of 2H-thiazolo[3,2-a]pyrimidine compounds and their binding affinities for anti-apoptotic Bcl-2 family proteins.
Xu Y; Zhou M; Li Y; Li C; Zhang Z; Yu B; Wang R
ChemMedChem; 2013 Aug; 8(8):1345-52. PubMed ID: 23794243
[TBL] [Abstract][Full Text] [Related]
2. De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.
Ding X; Li Y; Lv L; Zhou M; Han L; Zhang Z; Ba Q; Li J; Wang H; Liu H; Wang R
ChemMedChem; 2013 Dec; 8(12):1986-2014. PubMed ID: 24124106
[TBL] [Abstract][Full Text] [Related]
3. Discovery and development of thiazolo[3,2-a]pyrimidinone derivatives as general inhibitors of Bcl-2 family proteins.
Zhou B; Li X; Li Y; Xu Y; Zhang Z; Zhou M; Zhang X; Liu Z; Zhou J; Cao C; Yu B; Wang R
ChemMedChem; 2011 May; 6(5):904-21. PubMed ID: 21520420
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking studies of anti-apoptotic BCL-2, BCL-XL, and MCL-1 proteins with ginsenosides from Panax ginseng.
Sathishkumar N; Sathiyamoorthy S; Ramya M; Yang DU; Lee HN; Yang DC
J Enzyme Inhib Med Chem; 2012 Oct; 27(5):685-92. PubMed ID: 21919598
[TBL] [Abstract][Full Text] [Related]
6. Mapping the BH3 Binding Interface of Bcl-xL, Bcl-2, and Mcl-1 Using Split-Luciferase Reassembly.
Campbell ST; Carlson KJ; Buchholz CJ; Helmers MR; Ghosh I
Biochemistry; 2015 Apr; 54(16):2632-43. PubMed ID: 25844633
[TBL] [Abstract][Full Text] [Related]
7. Anti-apoptosis proteins Mcl-1 and Bcl-xL have different p53-binding profiles.
Yao H; Mi S; Gong W; Lin J; Xu N; Perrett S; Xia B; Wang J; Feng Y
Biochemistry; 2013 Sep; 52(37):6324-34. PubMed ID: 23977882
[TBL] [Abstract][Full Text] [Related]
8. Phytosterols and triterpenes from
Adewole KE; Ishola AA
J Recept Signal Transduct Res; 2019 Feb; 39(1):87-97. PubMed ID: 31215288
[TBL] [Abstract][Full Text] [Related]
9. Profiling of the Bcl-2/Bcl-X(L)-binding sites on type 1 IP(3) receptor.
Monaco G; Beckers M; Ivanova H; Missiaen L; Parys JB; De Smedt H; Bultynck G
Biochem Biophys Res Commun; 2012 Nov; 428(1):31-5. PubMed ID: 23058917
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics study of small molecule inhibitors of the Bcl-2 family.
Acoca S; Cui Q; Shore GC; Purisima EO
Proteins; 2011 Sep; 79(9):2624-36. PubMed ID: 21721047
[TBL] [Abstract][Full Text] [Related]
11. Characterization and expression analyses of anti-apoptotic Bcl-2-like genes NR-13, Mcl-1, Bcl-X1, and Bcl-X2 in Atlantic cod (Gadus morhua).
Feng CY; Rise ML
Mol Immunol; 2010 Jan; 47(4):763-84. PubMed ID: 19923001
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and activity evaluation of broad-spectrum small-molecule inhibitors of anti-apoptotic Bcl-2 family proteins: characteristics of broad-spectrum protein binding and its effects on anti-tumor activity.
Zheng CH; Yang H; Zhang M; Lu SH; Shi D; Wang J; Chen XH; Ren XH; Liu J; Lv JG; Zhu J; Zhou YJ
Bioorg Med Chem Lett; 2012 Jan; 22(1):39-44. PubMed ID: 22172701
[TBL] [Abstract][Full Text] [Related]
13. 3-Thiomorpholin-8-oxo-8H-acenaphtho [1,2-b] pyrrole-9-carbonitrile (S1) derivatives as pan-Bcl-2-inhibitors of Bcl-2, Bcl-xL and Mcl-1.
Song T; Li X; Chang X; Liang X; Zhao Y; Wu G; Xie S; Su P; Wu Z; Feng Y; Zhang Z
Bioorg Med Chem; 2013 Jan; 21(1):11-20. PubMed ID: 23206987
[TBL] [Abstract][Full Text] [Related]
14. Flexibility enables to discriminate between ligands: Lessons from structural ensembles of Bcl-xl and Mcl-1.
Maity A; Majumdar S; Ghosh Dastidar S
Comput Biol Chem; 2018 Dec; 77():17-27. PubMed ID: 30195235
[TBL] [Abstract][Full Text] [Related]
15. A conserved hydrophobic core at Bcl-xL mediates its structural stability and binding affinity with BH3-domain peptide of pro-apoptotic protein.
Feng Y; Zhang L; Hu T; Shen X; Ding J; Chen K; Jiang H; Liu D
Arch Biochem Biophys; 2009 Apr; 484(1):46-54. PubMed ID: 19161970
[TBL] [Abstract][Full Text] [Related]
16. Anti-tumor pyrimidinylpiperazines bind to the prosurvival Bcl-2 protein family member Bcl-XL.
Shallal HM; Faridi JS; Russu WA
Bioorg Med Chem Lett; 2011 Mar; 21(5):1325-8. PubMed ID: 21300543
[TBL] [Abstract][Full Text] [Related]
17. Structure-based design of rhodanine-based acylsulfonamide derivatives as antagonists of the anti-apoptotic Bcl-2 protein.
Li HQ; Yang J; Ma S; Qiao C
Bioorg Med Chem; 2012 Jul; 20(14):4194-200. PubMed ID: 22739087
[TBL] [Abstract][Full Text] [Related]
18. From meiogynin A to the synthesis of dual inhibitors of Bcl-xL and Mcl-1 anti-apoptotic proteins.
Desrat S; Remeur C; Gény C; Rivière G; Colas C; Dumontet V; Birlirakis N; Iorga BI; Roussi F
Chem Commun (Camb); 2014 Aug; 50(62):8593-6. PubMed ID: 24956071
[TBL] [Abstract][Full Text] [Related]
19. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
[TBL] [Abstract][Full Text] [Related]
20. Terphenyl-Based Bak BH3 alpha-helical proteomimetics as low-molecular-weight antagonists of Bcl-xL.
Yin H; Lee GI; Sedey KA; Kutzki O; Park HS; Orner BP; Ernst JT; Wang HG; Sebti SM; Hamilton AD
J Am Chem Soc; 2005 Jul; 127(29):10191-6. PubMed ID: 16028929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
